Polarean Imaging plc (AIM: POLX), the medical imaging technology company, with a proprietary drug?device combination product for the magnetic resonance imaging (MRI) market, notes that its partner company Amphion Innovations plc (“Amphion”), has pledged its holding of 18,372,523 shares in Polarean as additional security against its loan facility with its debt provider (the “Lender”).
April 1, 2019
· 1 min read